When Kristen Vlasak chose to participate in the Genetic Insights Project, a research study by Nebraska Medicine, she didn’t think much of it. What Vlasak didn’t realize at the time was that her result would trigger a series of tests that uncovered vital information for her entire family.

With one in eight women receiving a diagnosis in their lifetime, annual mammograms remain an essential, life-saving screening tool. Early detection offers patients more options with better outcomes, as it did for Michelle in December 2024.

When Gretchen Oltman scheduled a mammogram in fall 2024, she wasn’t worried. She felt fine. That routine visit set off a chain of events that would change her life – and ultimately lead her to advocate for others facing the same uncertainty she once felt.

The Fred & Pamela Buffett Cancer Center – Kearney is set to open in December 2024. It is a 53,000-square-foot facility that will offer comprehensive cancer care to patients in central Nebraska.

In March 2024, Gina Marchio embarked on an insightful journey through genetic screening. Marchio hoped to learn what her DNA could tell her about her future health.

Genetic testing has become an increasingly important tool in health care, offering insights into our risk for certain conditions and guiding treatment decisions.

Although Lynch syndrome isn’t common in the context of all cancers, it is the most common type of inherited cancer syndrome, affecting about 1 in every 280 people.

Risk assessment helps to determine whether a woman is at average or high risk of breast cancer.